Dr Paula Cevaal
Research Fellow
Department of Infectious Diseases
12 Scholarly works
5 Projects
HIGHLIGHTS
2025
Research contracts (non-grants)
CDA With Certest Biotech for Supply of LNP
2025
Research grants (international)
Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression
2025
Journal article
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV–hepatitis B virus co-infection model system
DOI: 10.1128/spectrum.00809-252025
Journal article
CRISPR/Cas9 for achieving postintervention HIV control
DOI: 10.1097/COH.00000000000009632025
Journal article
Efficient mRNA delivery to resting T cells to reverse HIV latency
DOI: 10.1038/s41467-025-60001-22025
Journal article
HIV Tat as a latency reversing agent: turning the tables on viral persistence
DOI: 10.3389/fimmu.2025.15711512024
Research contracts (non-grants)
In Vivo Analysis of Lung Targetting LNP
RECENT SCHOLARLY WORKS
2023
Thesis / Dissertation
Targeting the untargetable: Eliminating HIV latency using nanoparticle delivery systems
2022
Journal article
On predicting heterogeneity in nanoparticle dosage
DOI: 10.1016/j.mbs.2022.1089282022
Journal article
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
DOI: 10.3791/64259-v2022
Journal article
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
DOI: 10.3791/642592022
Journal article
An Inspiring Journey of Hope and Persistence: Life Lessons with Françoise Barré-Sinoussi
DOI: 10.3390/v140511082021
Journal article
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
DOI: 10.1021/acsnano.0c09514
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Leveraging mRNA and Lipid Nanoparticle Technology to Develop a Cure for HIV
2025
Research contracts (non-grants)
In Vivo CAR Using Site-Specific Editing (ICARUS)